Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ina Giegling

Showing results (91-100 of 191) with videos related to

Pageof 20
Sort By:
The International Journal of Neuropsychopharmacology|January 17, 2012
Sensorimotor gating and D2 receptor signalling: evidence from a molecular genetic approachChristoph Völter, Michael Riedel, Nicola Wöstmann, et al.
Journal of Psychiatric Research|July 6, 2010
Homer-1 polymorphisms are associated with psychopathology and response to treatment in schizophrenic patientsIlja Spellmann, Dan Rujescu, Richard Musil, et al.
Pteridines|September 26, 2017
Reciprocal moderation by <i>Toxoplasma gondii</i> seropositivity and blood phenylalanine - tyrosine ratio of their associations with trait aggressionAshwin Jacob Mathai, Christopher A Lowry, Thomas B Cook, et al.
Human Molecular Genetics|November 16, 2007
Strong evidence that GNB1L is associated with schizophreniaNigel M Williams, Beate Glaser, Nadine Norton, et al.
Journal of Psychiatric Research|November 24, 2015
Combined Toxoplasma gondii seropositivity and high blood kynurenine--Linked with nonfatal suicidal self-directed violence in patients with schizophreniaOlaoluwa Okusaga, Erica Duncan, Patricia Langenberg, et al.
Plos One|February 18, 2010
Plasma protein biomarkers for depression and schizophrenia by multi analyte profiling of case-control collectionsEnrico Domenici, David R Willé, Federica Tozzi, et al.
Journal of Psychiatric Research|July 23, 2013
CNTNAP2 polymorphisms and structural brain connectivity: a diffusion-tensor imaging studyChristian Clemm von Hohenberg, Marlene C Wigand, Marek Kubicki, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|June 14, 2017
Cognitive Characterization of Schizophrenia Risk Variants Involved in Synaptic Transmission: Evidence of CACNA1C's Role in Working MemoryDonna Cosgrove, Omar Mothersill, Kimberley Kendall, et al.
Archives of General Psychiatry|October 6, 2010
Biological validation of increased schizophrenia risk with NRG1, ERBB4, and AKT1 epistasis via functional neuroimaging in healthy controlsKristin K Nicodemus, Amanda J Law, Eugenia Radulescu, et al.
Molecular Medicine (Cambridge, Mass.)|June 7, 2012
Common variants of the genes encoding erythropoietin and its receptor modulate cognitive performance in schizophreniaAnne Kästner, Sabrina Grube, Ahmed El-Kordi, et al.
Pageof 20

Showing results (91-100 of 191) with videos related to

Sort By:
Pageof 20
The International Journal of Neuropsychopharmacology|January 17, 2012
Sensorimotor gating and D2 receptor signalling: evidence from a molecular genetic approachChristoph Völter, Michael Riedel, Nicola Wöstmann, et al.
Journal of Psychiatric Research|July 6, 2010
Homer-1 polymorphisms are associated with psychopathology and response to treatment in schizophrenic patientsIlja Spellmann, Dan Rujescu, Richard Musil, et al.
Pteridines|September 26, 2017
Reciprocal moderation by <i>Toxoplasma gondii</i> seropositivity and blood phenylalanine - tyrosine ratio of their associations with trait aggressionAshwin Jacob Mathai, Christopher A Lowry, Thomas B Cook, et al.
Human Molecular Genetics|November 16, 2007
Strong evidence that GNB1L is associated with schizophreniaNigel M Williams, Beate Glaser, Nadine Norton, et al.
Journal of Psychiatric Research|November 24, 2015
Combined Toxoplasma gondii seropositivity and high blood kynurenine--Linked with nonfatal suicidal self-directed violence in patients with schizophreniaOlaoluwa Okusaga, Erica Duncan, Patricia Langenberg, et al.
Plos One|February 18, 2010
Plasma protein biomarkers for depression and schizophrenia by multi analyte profiling of case-control collectionsEnrico Domenici, David R Willé, Federica Tozzi, et al.
Journal of Psychiatric Research|July 23, 2013
CNTNAP2 polymorphisms and structural brain connectivity: a diffusion-tensor imaging studyChristian Clemm von Hohenberg, Marlene C Wigand, Marek Kubicki, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|June 14, 2017
Cognitive Characterization of Schizophrenia Risk Variants Involved in Synaptic Transmission: Evidence of CACNA1C's Role in Working MemoryDonna Cosgrove, Omar Mothersill, Kimberley Kendall, et al.
Archives of General Psychiatry|October 6, 2010
Biological validation of increased schizophrenia risk with NRG1, ERBB4, and AKT1 epistasis via functional neuroimaging in healthy controlsKristin K Nicodemus, Amanda J Law, Eugenia Radulescu, et al.
Molecular Medicine (Cambridge, Mass.)|June 7, 2012
Common variants of the genes encoding erythropoietin and its receptor modulate cognitive performance in schizophreniaAnne Kästner, Sabrina Grube, Ahmed El-Kordi, et al.
Pageof 20